Documents

April 2012

• GAO Says More Action Needed To Stem Medicare Fraud
• House Oversight Committee Staff Report Details Medicaid Gaps Leading To Fraud
• GAO Calls For Improvements In Federal Oversight Of Medicaid Payments
• House W&M Oversight Panel Launches Probe Into CMS Fraud-Fighting Programs
• Senate Health Committee Approves User Fee Bill Without Device Reforms Sought By Consumer Advocates
• NIOSH Expands Peer Review Of Diacetyl, 2,3-pentanedione Standard Critera
• Updated House Leadership Memo Outlining Committees' Reconciliation Proposals
• Stakeholders, Lawmakers React To Senate Health Committee' User Fee Bill
• House User Fee Bill Lacks Drug Supply Chain Language Heading Into Thursday Markup
• CMS Issues Proposed Hospital IPPS Rule
• NCPA Offers Senators Recommendations On PDUFA Reauthorization
• Public Citizen Raises Strong Concerns With Senate User Fee Bill In Letter To Health Panel
• Text Of Amendments Filed For Senate User Fee Markup
• AHA Outlines Appropriations Priorities
• Reactions To Medicare Trustees Report
• E&C Budget Proposals Would Slice Deficit By $115B
• Medicare Trustee Report: Medicare Solvent Until 2024
• CBO Score Of Energy & Commerce Medicaid/CHIP Package
• FDA Announces Final Strategic Plan For Foods And Veterinary Medicine Program
• Victims Group To Chamber: Back Off On Reg Opposition
• Senate Panel Unveils User Fee Manager's Amendment That Includes Some GOP Provisions
• FDA Outlines Advancements In Drug Safety Since FDAAA
• GAO Says MA Star Rating Demo Undermined By High Costs
• FDA Report Outlines Focus On Global Cooperation For Product Safety
• CMS Report Shows Short-Term Savings To Medicare Due To ACA